Antibiotic News and Research RSS Feed - Antibiotic News and Research

Antibiotics are drugs used to treat infections caused by bacteria and other microorganisms.
Only 52% of women receive low-cost treatment to prevent babies death

Only 52% of women receive low-cost treatment to prevent babies death

A major international study of more than 303 000 births in 29 low-income and middle-income countries has found that only half (52%) of women who are eligible to receive a simple, effective, low-cost treatment to prevent death and disability in their newborn babies are getting it. [More]
First Edition: August 12, 2014

First Edition: August 12, 2014

Today's headlines include stories about how the federal government's experience with healthcare.gov has led to the creation of the U.S. Digital Service. [More]
Researchers discover highly virulent, multidrug resistant form of pathogen in Ohio

Researchers discover highly virulent, multidrug resistant form of pathogen in Ohio

A team of clinician researchers has discovered a highly virulent, multidrug resistant form of the pathogen, Pseudomonas aeruginosa, in patient samples in Ohio. [More]
Forecast report on U.S. orthopedic large joint reconstruction device market

Forecast report on U.S. orthopedic large joint reconstruction device market

Reportlinker.com announces that a new market research report is available in its catalogue: U.S. Orthopedic Large Joint Reconstruction Device Market. [More]
Brazilian orthopedic large joint reconstruction device market expected to reach $502.4M by 2019

Brazilian orthopedic large joint reconstruction device market expected to reach $502.4M by 2019

Reportlinker.com announces that a new market research report is available in its catalogue: Brazilian Large Bone & Joint Orthopedic Devices Market. [More]
TAXIS acquires novel antimicrobial drug candidates from Biota

TAXIS acquires novel antimicrobial drug candidates from Biota

TAXIS Pharmaceuticals, Inc. today announced the acquisition of a group of novel antimicrobial drug candidates from Biota Pharmaceuticals Inc. of Atlanta, GA. [More]
Exposure of pregnant women and fetuses to antibacterial compounds leads to health risk

Exposure of pregnant women and fetuses to antibacterial compounds leads to health risk

As the Food and Drug Administration (FDA) mulls over whether to rein in the use of common antibacterial compounds that are causing growing concern among environmental health experts, scientists are reporting today that many pregnant women and their fetuses are being exposed to these substances. [More]
Soligenix demonstrates improved immunogenicity and rapid action of anthrax vaccine, VeloThrax

Soligenix demonstrates improved immunogenicity and rapid action of anthrax vaccine, VeloThrax

Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today results demonstrating the improved immunogenicity and rapid action of its anthrax vaccine, VeloThrax™. [More]
Discovery lays groundwork for new class of antibiotics for Staphylococcus aureus infections

Discovery lays groundwork for new class of antibiotics for Staphylococcus aureus infections

St. Jude Children's Research Hospital scientists have discovered an enzyme that regulates production of the toxins that contribute to potentially life-threatening Staphylococcus aureus infections. The study recently appeared in the scientific journal the Proceedings of the National Academy of Sciences. [More]
PET-CT using FDG-labeled leucocytes may help in detecting infection in patients with acute pancreatitis

PET-CT using FDG-labeled leucocytes may help in detecting infection in patients with acute pancreatitis

A new study diagnosing infection in patients with pancreatic fluid collections may swiftly and accurately rule out active infection in the body. [More]
Exploiting chemical response from body's immune system to attack pathogens using copper

Exploiting chemical response from body's immune system to attack pathogens using copper

Harnessing a natural process in the body that pumps lethal doses of copper to fungi and bacteria shows promise as a new way to kill infectious microbes, a team of scientists at Duke University report. [More]
Viewpoints: GOP lawsuit against Obama on health law is not a 'stunt'; 'wisdom' lacking in the House; the danger of cyberattacks on hospitals

Viewpoints: GOP lawsuit against Obama on health law is not a 'stunt'; 'wisdom' lacking in the House; the danger of cyberattacks on hospitals

"So sue me" is President Obama's message to Congress. And on Wednesday the House of Representatives took up his taunt, authorizing a lawsuit to challenge the president's failure to faithfully execute provisions of the Affordable Care Act as passed by Congress. The House lawsuit is no "stunt," as Mr. Obama has characterized it. [More]
Virginia Mason earns Marine Stewardship Council certification

Virginia Mason earns Marine Stewardship Council certification

Virginia Mason announced today it is the first hospital in the United States to earn Marine Stewardship Council (MSC) certification for its commitment to serving seafood grown and harvested by certified, environmentally sustainable methods. [More]
Findings reveal new way to identify non-antibiotic drugs that could help curb bacterial infections

Findings reveal new way to identify non-antibiotic drugs that could help curb bacterial infections

About 100 drugs already approved by the U.S. Food and Drug Administration (FDA) for other purposes can also prevent the growth of certain bacterial pathogens inside human cells, including those that cause Legionnaires' disease, brucellosis, and Mediterranean spotted fever. [More]
Pneumococcal pneumonia mortality falling

Pneumococcal pneumonia mortality falling

Between 2000 and 2013 there has been an increase in the early prescription of antibiotics and use of combination therapy in patients with pneumococcal pneumonia, researchers report. [More]
Surgical patient safety program significantly reduces cardiac surgical site infections

Surgical patient safety program significantly reduces cardiac surgical site infections

A common postoperative complication after open heart operations-infection at the surgical site-has been reduced by 77 percent at a Canadian hospital through its participation in the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP-), according to a new case study presented at the 2014 ACS NSQIP National Conference. [More]
Continuous antibiotics for children with antenatal hydronephrosis not necessary, study finds

Continuous antibiotics for children with antenatal hydronephrosis not necessary, study finds

Up to 5 percent of all prenatal ultrasounds uncover antenatal hydronephrosis, or enlarged kidneys, the most commonly detected prenatal abnormality in the United States. Many children with this abnormality are treated continually with preventive antibiotics for the first few years of life with the hopes of preventing the condition's associated urinary tract infections. [More]
Funding for antibiotic research in the UK are inadequate, study reveals

Funding for antibiotic research in the UK are inadequate, study reveals

Less than 1% of research funding awarded by public and charitable bodies to UK researchers in 2008–13 was awarded for research on antibiotics, according to new research published in The Lancet Infectious Diseases. [More]
Deleting enzyme favorably impacts behaviors associated with autistic behaviors

Deleting enzyme favorably impacts behaviors associated with autistic behaviors

Fragile X syndrome (FXS) is a genetic disorder that causes obsessive-compulsive and repetitive behaviors, and other behaviors on the autistic spectrum, as well as cognitive deficits. It is the most common inherited cause of mental impairment and the most common cause of autism. [More]
Researchers uncover how malaria parasite becomes resistant to fosmidomycin drug

Researchers uncover how malaria parasite becomes resistant to fosmidomycin drug

Researchers have uncovered a way the malaria parasite becomes resistant to an investigational drug. The discovery, at Washington University School of Medicine in St. Louis, also is relevant for other infectious diseases including bacterial infections and tuberculosis. [More]